Study of Targeted Therapy for HER2-Positive Metastatic Breast Cancer

preview_player
Показать описание
Ian E. Krop, MD, PhD, provides an overview of a study comparing HER2-targeted antibody-drug conjugate DS-8201a (trastuzumab deruxtecan) with the current standard of care in people with HER2-positive metastatic breast cancer previously treated with T-DM1.

  1. Dana-Farber Cancer Institute
  2. Dana-Farber Cancer Institute
  3. DFCI
  4. Dana-Farber
  5. cancer
  6. breast cancer
Рекомендации по теме
Study of Targeted 0:03:19

Study of Targeted Therapy for HER2-Positive Metastatic Breast Cancer

What Are Targeted 0:05:59

What Are Targeted Therapies for Cancer Treatment?

Live Well Breathe 0:59:45

Live Well Breathe Better - Lung Cancer: Targeted Therapy for lung cancer treatment

Keynote Lecture: Targeted 0:33:52

Keynote Lecture: Targeted Therapies in Lung Cancer 2.0 – Advances and Promises

What are ‘targeted’ 0:01:29

What are ‘targeted’ cancer drugs? | Cancer Research UK

Management of Differentiated 0:20:02

Management of Differentiated Thyroid Carcinoma in the Era of Targeted Therapy

What is targeted 0:01:37

What is targeted therapy for lung cancer?

Hitting the Mark 0:20:35

Hitting the Mark with Targeted Therapy: BRAF, NRAS, CKIT, etc...Sullivan

Inside the Issue: 0:59:20

Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

Novel Targeted Therapy 0:55:05

Novel Targeted Therapy for Low-Grade Lymphoid Malignancies in Older Adults by Dr. Krem

Targeted Therapy and 0:06:08

Targeted Therapy and Immunotherapy for Lung Cancer | Dr. Laura Chow

Cancer Treatment: Targeted 0:00:50

Cancer Treatment: Targeted Therapy

What Is Targeted 0:01:14

What Is Targeted Therapy For Lung Cancer? | Lung Foundation Australia

Targeted therapy and 0:01:14

Targeted therapy and immunotherapy combination for bladder cancer treatment

Targeted Therapy 0:02:05

Targeted Therapy

An innovative approach 0:05:35

An innovative approach to cancer treatment – Targeted therapy and Immunotherapy

Chemotherapy, Targeted Therapy, 0:34:15

Chemotherapy, Targeted Therapy, and Immunotherapy

Recent advances in 0:02:42

Recent advances in targeted therapy for head and neck cancer

Locally advanced NSCLC: 0:25:26

Locally advanced NSCLC: Combination therapy with targeted and immunotherapy agents

Targeted treatment with 0:20:24

Targeted treatment with EGFR TKIs: Front line options

Gene Targeted Therapy 0:59:01

Gene Targeted Therapy for Non Small Cell Lung Cancer

Targeted Therapy in 0:05:53

Targeted Therapy in Non-Small Cell Lung Cancer

Extreme Rare Mutations 0:18:41

Extreme Rare Mutations in Lung Cancer (ROS1, TRK, HER2): Treatment opportunities

The Current State 0:50:01

The Current State of Psoriasis Treatment with Targeted Therapy